A Method of Producing Carcinoma in Upper Aerodigestive Tree and Esophagus of the Syrian Golden Hamster Using Wounding and Instillation of N-Methylnitrosourea

Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, Minnesota USA.
Cancer Epidemiology Biomarkers & Prevention (Impact Factor: 4.13). 09/2007; 16(8):1644-50. DOI: 10.1158/1055-9965.EPI-06-1075
Source: PubMed


Details of a method for producing carcinoma of the aerodigestive tree of the Syrian golden hamster and the use of this model to evaluate putative agents for chemoprevention of these carcinomas are described. The method produces a majority of squamous carcinomas of the trachea and glottis that follow squamous metaplasia of respiratory epithelium. In addition, seen are adenocarcinomas arising in glands of the respiratory tree. Squamous carcinomas of the digestive epithelium arise in primary squamous epithelium. These tumors of digestive epithelium have a growth pattern that differs from that of the respiratory epithelium in that they grow and invade without filling the epithelial layer with tumor cells.

4 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer is the leading cause of new cancer cases and also is the number one cause of cancer death in both male and females in the United States and the world. Lung cancer is histologically separated into either small-cell (SCLC) or nonsmall-cell lung cancer (NSCLC). NSCLC is much more common, and can occur in the periphery (adenocarcinomas) or central airways (squamous cell carcinomas). The literature pertaining to lung cancer adjuvant therapy and inhalation lung cancer chemoprevention was reviewed. It is argued that inhalation of chemotherapy as an adjuvant in Stage II NSCC and inhalation of chemopreventive agents in Stage I adenocarcinomas are direct paths to improve lung cancer therapy as well as demonstrate the utility of inhalation therapy. If successful, inhalation delivery may be extended to the treatment of other types of lung cancer.
    Journal of Aerosol Medicine and Pulmonary Drug Delivery 08/2010; 23(4):181-7. DOI:10.1089/jamp.2009.0787 · 2.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Preclinical animal models to study laryngeal cancer are nonexistent. The purpose of this study was to describe a novel mice laryngeal cancer model.MethodsA total of 18 six-week-old A/J mice were used. Animals underwent microdirect laryngoscopy, superficial larynx scratching, and instillation of N-methyl-N-nitrosourea (MNU) at 2 different concentrations (15 μL and 30 μL) or dimethyl sulfoxide (DMSO) to the control group directly to the larynx. Mice received a total of 5 instillations of MNU or DMSO at 1-week intervals. Mice were euthanized at 20 and 30 weeks after the last intervention and laryngeal histology was analyzed.ResultsLaryngeal instillation of MNU caused a 60% cancer conversion in the study group.Conclusion Our findings demonstrate the feasibility of developing a murine laryngeal carcinogenesis model using direct topical instillation of MNU. This is the first murine model of laryngeal cancer and has great potential for evaluating new agents for chemoprevention and treatment for laryngeal carcinoma. © 2013 Wiley Periodicals, Inc. Head Neck, 2013
    Head & Neck 12/2014; 36(12). DOI:10.1002/hed.23536 · 2.64 Impact Factor